Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Mar 29, 2024

SELL
$48.54 - $61.64 $156,978 - $199,343
-3,234 Closed
0 $0
Q1 2023

Mar 29, 2024

BUY
$46.12 - $65.71 $56,912 - $81,086
1,234 Added 61.7%
3,234 $160 Million
Q4 2022

Mar 29, 2024

BUY
$45.51 - $65.08 $91,020 - $130,160
2,000 New
2,000 $114 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Kapitalo Investimentos Ltda Portfolio

Follow Kapitalo Investimentos Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Kapitalo Investimentos Ltda with notifications on news.